Duran Sürün

728 total citations
25 papers, 493 citations indexed

About

Duran Sürün is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Duran Sürün has authored 25 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Immunology. Recurrent topics in Duran Sürün's work include CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (4 papers) and Pluripotent Stem Cells Research (4 papers). Duran Sürün is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (4 papers) and Pluripotent Stem Cells Research (4 papers). Duran Sürün collaborates with scholars based in Germany, Sweden and United Kingdom. Duran Sürün's co-authors include Frank Schnütgen, Frank Buchholz, Jovan Mircetic, Harald von Melchner, Maciej Paszkowski‐Rogacz, Katrin Neumann, Min Ae Lee‐Kirsch, Nina Kurrle, Ana Tomasovic and Dieter Steinhilber and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Duran Sürün

24 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duran Sürün Germany 12 393 92 85 71 59 25 493
Kevin Patel United States 5 428 1.1× 44 0.5× 49 0.6× 130 1.8× 79 1.3× 7 671
Kasey Jividen United States 11 512 1.3× 41 0.4× 67 0.8× 73 1.0× 108 1.8× 15 695
Xuexiu Zheng South Korea 17 740 1.9× 27 0.3× 119 1.4× 26 0.4× 68 1.2× 39 822
Kunhua Qin United States 10 325 0.8× 23 0.3× 38 0.4× 50 0.7× 22 0.4× 16 443
Raquela J. Thomas United States 8 479 1.2× 128 1.4× 83 1.0× 57 0.8× 72 1.2× 10 595
Florencia Cano United Kingdom 15 418 1.1× 67 0.7× 68 0.8× 80 1.1× 135 2.3× 20 608
Rahul Sanawar India 7 210 0.5× 21 0.2× 42 0.5× 34 0.5× 17 0.3× 14 310
Nadya Al‐Yacoub Saudi Arabia 12 358 0.9× 60 0.7× 50 0.6× 115 1.6× 96 1.6× 17 519
Shi Hao Tan Singapore 13 419 1.1× 127 1.4× 140 1.6× 32 0.5× 106 1.8× 35 650

Countries citing papers authored by Duran Sürün

Since Specialization
Citations

This map shows the geographic impact of Duran Sürün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duran Sürün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duran Sürün more than expected).

Fields of papers citing papers by Duran Sürün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duran Sürün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duran Sürün. The network helps show where Duran Sürün may publish in the future.

Co-authorship network of co-authors of Duran Sürün

This figure shows the co-authorship network connecting the top 25 collaborators of Duran Sürün. A scholar is included among the top collaborators of Duran Sürün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duran Sürün. Duran Sürün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tretbar, Sandy, Joel G. Rurik, Even H Rustad, et al.. (2024). Non-viral vectors for chimeric antigen receptor immunotherapy. Nature Reviews Methods Primers. 4(1). 5 indexed citations
3.
Schmitt, Lukas Theo, et al.. (2023). Quantification of evolved DNA-editing enzymes at scale with DEQSeq. Genome biology. 24(1). 254–254. 3 indexed citations
4.
Schmitt, Lukas Theo, et al.. (2023). Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering. Nucleic Acids Research. 51(10). 5285–5297. 7 indexed citations
5.
Heinicke, Ulrike, Duran Sürün, Koraljka Husnjak, et al.. (2023). Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome. Cell chemical biology. 30(10). 1277–1294.e12. 3 indexed citations
6.
Sidorova, Olga Alexandra, Alexander Hennig, Martina Augsburg, et al.. (2022). Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing. Cancer Research. 82(17). 3002–3015. 28 indexed citations
7.
Angioni, Carlo, Duran Sürün, Dominique Thomas, et al.. (2022). Knock-out of 5-lipoxygenase in overexpressing tumor cells—consequences on gene expression and cellular function. Cancer Gene Therapy. 30(1). 108–123. 8 indexed citations
8.
Seuter, Sabine, Duran Sürün, Dominique Thomas, et al.. (2022). Human 5-lipoxygenase regulates transcription by association to euchromatin. Biochemical Pharmacology. 203. 115187–115187. 11 indexed citations
9.
Sürün, Duran, et al.. (2022). Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines. Methods in molecular biology. 2508. 235–260. 1 indexed citations
10.
Ding, Li, Lukas Theo Schmitt, Melanie Brux, et al.. (2022). DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins. Life Science Alliance. 5(6). e202101321–e202101321. 5 indexed citations
11.
Sürün, Duran, Jovan Mircetic, Katrin Neumann, et al.. (2020). Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors. Genes. 11(5). 511–511. 93 indexed citations
12.
Shaid, Shabnam, Olesya Vakhrusheva, Sebastian E. Koschade, et al.. (2018). Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. 133(2). 168–179. 84 indexed citations
13.
Atlante, Sandra, Elisabetta Marini, Chiara Dianzani, et al.. (2018). α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis. Cell Death and Disease. 9(7). 756–756. 70 indexed citations
14.
Sürün, Duran, Harald von Melchner, & Frank Schnütgen. (2018). CRISPR/Cas9 genome engineering in hematopoietic cells. Drug Discovery Today Technologies. 28. 33–39. 13 indexed citations
15.
Sürün, Duran, Joachim Schwäble, Ana Tomasovic, et al.. (2017). High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing. Molecular Therapy — Nucleic Acids. 10. 1–8. 33 indexed citations
16.
Wittmann, Sandra K., Duran Sürün, Meike J. Saul, et al.. (2017). Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(5). 561–571. 6 indexed citations
17.
Sürün, Duran, Nina Kurrle, Hubert Serve, Harald von Melchner, & Frank Schnütgen. (2017). High efficiency gene correction in hematopoietic cells by donor-template-free CRISPR/Cas9 genome editing. Experimental Hematology. 53. S64–S64. 4 indexed citations
18.
Tomasovic, Ana, Nina Kurrle, Frank Wempe, et al.. (2016). Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function. Matrix Biology. 59. 109–120. 11 indexed citations
19.
Tomasovic, Ana, Nina Kurrle, Duran Sürün, et al.. (2015). Sestrin 2 Protein Regulates Platelet-derived Growth Factor Receptor β (Pdgfrβ) Expression by Modulating Proteasomal and Nrf2 Transcription Factor Functions. Journal of Biological Chemistry. 290(15). 9738–9752. 19 indexed citations
20.
Sürün, Duran, Birger Christensson, Birgitta Sander, et al.. (2015). Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes. Prostaglandins Leukotrienes and Essential Fatty Acids. 100. 33–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026